Showing results (11-20 of 369) with videos related to
Sort By:
Pageof 37
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2009
Starving the addiction: new opportunities for durable suppression of AR signaling in prostate cancerKaren E Knudsen, Howard I ScherBritish Journal of Cancer|October 23, 2018
Lessons from the SWITCH trial: changing glucocorticoids in the management of metastatic castration-resistant prostate cancer (mCRPC)Min Yuen Teo, Howard I ScherThe Oncologist|April 17, 2003
Clinical approaches to osseous metastases in prostate cancerMichael J Morris, Howard I ScherCritical Reviews in Oncology/Hematology|July 10, 2003
Optimizing targeted therapy and developing novel outcome measures for patients with advanced prostate cancer at Memorial Sloan-Kettering Cancer CenterMichael J Morris, Howard I ScherJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2005
Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axisHoward I Scher, Charles L SawyersClinical Chemistry|January 4, 2019
Circulating Tumor Cells in Prostate Cancer: From Discovery to Clinical UtilityKlaus Pantel, Claudia Hille, Howard I ScherClinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
The association between measures of progression and survival in castrate-metastatic prostate cancerHoward I Scher, Mary Warren, Glenn HellerCancer|July 17, 2015
Everolimus combined with gefitinib in patients with metastatic castration-resistant prostate cancer: Phase 1/2 results and signaling pathway implicationsDana E Rathkopf, Steven M Larson, Aseem Anand, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2007
Setting the bar in phase II trials: the use of historical data for determining "go/no go" decision for definitive phase III testingAndrew J Vickers, Vennus Ballen, Howard I ScherClinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2011
Circulating tumor cells as biomarkers in prostate cancerDaniel C Danila, Martin Fleisher, Howard I ScherPageof 37